News

Hologic’s planned importation, use, sale or offer to sell of Adiana system will infringe various patents owned by Conceptus including U.S. Patent Nos. 7506650, 7428904, 7237552, 6709667 and

Effective July 2009, Drug Discovery Research facility in Hyderabad will be known as Aurigene – Hyderabad. Thus, Aurigene will now operate from two locations: Bangalore and Hyderabad. In

As part of this acquisition, NuSil will transfer the manufacturing of the Bluestar Silicones pharmaceutical Simethicone business to NuSil’s FDA registered facility in Bakersfield, California. The company will

The trials, termed as EXPEDITION and EXPEDITION 2, are identical multicenter, randomized, double-blind and placebo-controlled trials. Each will include a treatment period that lasts one and half year

Cougar is currently conducting two Phase III trials for abiraterone acetate for the treatment of prostate cancer. The first Phase III trial is testing abiraterone acetate in patients

Last October, the company submitted a new drug application to the US Food and Drug Administration (FDA) requesting marketing approval of Qutenza. In December 2008, it was accepted

These studies showed survival benefit in two relevant animal species, which is the minimum requirement for establishing the efficacy of new drugs used in countering bioterrorism. Raxibacumab is

In the oral decision, the District Court dismissed all of the claims filed by MGH except that made under Massachusetts General Law chapter 93A, a consumer protection law

As per the agreement, BioLabs will transfer rights to its pipeline of Curaxin anticancer molecules to the joint venture, and BCV will fund about $15 million in three